583 related articles for article (PubMed ID: 10395703)
21. A mucosally administered recombinant fusion protein vaccine against schistosomiasis protecting against immunopathology and infection.
Lebens M; Sun JB; Sadeghi H; Bäckström M; Olsson I; Mielcarek N; Li BL; Capron A; Czerkinsky C; Holmgren J
Vaccine; 2003 Jan; 21(5-6):514-20. PubMed ID: 12531651
[TBL] [Abstract][Full Text] [Related]
22. IL-10 is crucial for the transition from acute to chronic disease state during infection of mice with Schistosoma mansoni.
Sadler CH; Rutitzky LI; Stadecker MJ; Wilson RA
Eur J Immunol; 2003 Apr; 33(4):880-8. PubMed ID: 12672053
[TBL] [Abstract][Full Text] [Related]
23. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
El Ridi R; Tallima H
Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
[TBL] [Abstract][Full Text] [Related]
24. Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine.
Tarkowski A; Sun JB; Holmdahl R; Holmgren J; Czerkinsky C
Arthritis Rheum; 1999 Aug; 42(8):1628-34. PubMed ID: 10446861
[TBL] [Abstract][Full Text] [Related]
25. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
Farah IO; Johansson M; Lövgren-Bengtson K; Hau J
Scand J Immunol; 2000 Mar; 51(3):237-43. PubMed ID: 10736092
[TBL] [Abstract][Full Text] [Related]
26. Expression of a Schistosoma mansoni 28-kilodalton glutathione S-transferase in the livers of transgenic mice and its effect on parasite infection.
Xu X; Lemaire C; Grzych JM; Pierce RJ; Raccurt M; Mullier F; Zerimech F; Decavel JP; Peyrol S; Liu J; Fontaine J; Lafitte S; Capron A; Cesbron JY
Infect Immun; 1997 Sep; 65(9):3867-74. PubMed ID: 9284165
[TBL] [Abstract][Full Text] [Related]
27. Diminished immunopathology in Schistosoma mansoni infection following intranasal administration of cholera toxin B-immunodominant peptide conjugate correlates with enhanced transforming growth factor-beta production by CD4 T cells.
Hernandez HJ; Rutitzky LI; Lebens M; Holmgren J; Stadecker MJ
Parasite Immunol; 2002 Aug; 24(8):423-7. PubMed ID: 12406196
[TBL] [Abstract][Full Text] [Related]
28. Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.
Wiedermann U; Jahn-Schmid B; Lindblad M; Rask C; Holmgren J; Kraft D; Ebner C
Int Immunol; 1999 Jul; 11(7):1131-8. PubMed ID: 10383946
[TBL] [Abstract][Full Text] [Related]
29. Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni.
Boulanger D; Reid GD; Sturrock RF; Wolowczuk I; Balloul JM; Grezel D; Pierce RJ; Otieno MF; Guerret S; Grimaud JA
Parasite Immunol; 1991 Sep; 13(5):473-90. PubMed ID: 1956696
[TBL] [Abstract][Full Text] [Related]
30. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
Nyström-Asklin J; Adamsson J; Harandi AM
Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
[TBL] [Abstract][Full Text] [Related]
31. Control of schistosomiasis pathology by combination of Sm28GST DNA immunization and praziquantel treatment.
Dupré ; Herv M; Schacht AM; Capron A; Riveau G
J Infect Dis; 1999 Aug; 180(2):454-63. PubMed ID: 10395862
[TBL] [Abstract][Full Text] [Related]
32. Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile.
Jankovic D; Kullberg MC; Noben-Trauth N; Caspar P; Ward JM; Cheever AW; Paul WE; Sher A
J Immunol; 1999 Jul; 163(1):337-42. PubMed ID: 10384133
[TBL] [Abstract][Full Text] [Related]
33. Identification of Schistosoma mansoni antigens recognized by T cells of C57BL/6 mice immunized with gamma-irradiated cercariae.
Osman A; el Ridi R; Guirguis N; Dean DA
J Parasitol; 1994 Jun; 80(3):421-31. PubMed ID: 8195944
[TBL] [Abstract][Full Text] [Related]
34. Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: association of viral persistence with egg granuloma formation.
Actor JK; Marshall MA; Eltoum IA; Buller RM; Berzofsky JA; Sher A
Eur J Immunol; 1994 Dec; 24(12):3050-6. PubMed ID: 7805733
[TBL] [Abstract][Full Text] [Related]
35. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis.
Cheever AW; Williams ME; Wynn TA; Finkelman FD; Seder RA; Cox TM; Hieny S; Caspar P; Sher A
J Immunol; 1994 Jul; 153(2):753-9. PubMed ID: 8021510
[TBL] [Abstract][Full Text] [Related]
36. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice.
Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P
Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021
[TBL] [Abstract][Full Text] [Related]
37. Antibody responses to the fucosylated LacdiNAc glycan antigen in Schistosoma mansoni-infected mice and expression of the glycan among schistosomes.
Nyame AK; Leppänen AM; Bogitsh BJ; Cummings RD
Exp Parasitol; 2000 Dec; 96(4):202-12. PubMed ID: 11162373
[TBL] [Abstract][Full Text] [Related]
38. Induction of cytotoxic T-cell activity by the protective antigen of Schistosoma mansoni Sm28GST or its derived C-terminal lipopeptide.
Pancré V; Gras-Masse H; Delanoye A; Herno J; Capron A; Auriault C
Scand J Immunol; 1996 Nov; 44(5):485-92. PubMed ID: 8947600
[TBL] [Abstract][Full Text] [Related]
39. IFN-gamma, IL-12, and TNF-alpha are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12.
Hoffmann KF; Caspar P; Cheever AW; Wynn TA
J Immunol; 1998 Oct; 161(8):4201-10. PubMed ID: 9780194
[TBL] [Abstract][Full Text] [Related]
40. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
